The stock of Embecta Corp (EMBC) has seen a 0.60% increase in the past week, with a -19.68% drop in the past month, and a -22.77% decrease in the past quarter. The volatility ratio for the week is 1.32%, and the volatility levels for the past 30 days are at 4.66% for EMBC. The simple moving average for the past 20 days is -6.77% for EMBC’s stock, with a -32.73% simple moving average for the past 200 days.
Is It Worth Investing in Embecta Corp (NASDAQ: EMBC) Right Now?
The price-to-earnings ratio for Embecta Corp (NASDAQ: EMBC) is above average at 11.07x, Company’s 36-month beta value is 1.07.Analysts have differing opinions on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 3 as “hold,” and 0 as “sell.”
The public float for EMBC is 54.38M, and currently, short sellers hold a 5.03% ratio of that floaft. The average trading volume of EMBC on June 13, 2025 was 617.41K shares.
EMBC) stock’s latest price update
The stock price of Embecta Corp (NASDAQ: EMBC) has dropped by -0.69 compared to previous close of 10.11. Despite this, the company has seen a gain of 0.60% in its stock price over the last five trading days. globenewswire.com reported 2025-05-27 that PARSIPPANY, N.J., May 27, 2025 (GLOBE NEWSWIRE) — Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced that management will participate in the following investor events:
Analysts’ Opinion of EMBC
Many brokerage firms have already submitted their reports for EMBC stocks, with Mizuho repeating the rating for EMBC by listing it as a “Neutral.” The predicted price for EMBC in the upcoming period, according to Mizuho is $15 based on the research report published on April 10, 2025 of the current year 2025.
Morgan Stanley, on the other hand, stated in their research note that they expect to see EMBC reach a price target of $20, previously predicting the price at $13. The rating they have provided for EMBC stocks is “Equal-Weight” according to the report published on December 02nd, 2024.
BTIG Research gave a rating of “Buy” to EMBC, setting the target price at $26 in the report published on November 27th of the previous year.
EMBC Trading at -13.04% from the 50-Day Moving Average
After a stumble in the market that brought EMBC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -53.26% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at EMBC starting from Melcher David F, who purchase 10,000 shares at the price of $10.60 back on May 23 ’25. After this action, Melcher David F now owns 86,681 shares of Embecta Corp, valued at $105,995 using the latest closing price.
Melcher David F, the Director of Embecta Corp, purchase 13,000 shares at $13.67 during a trade that took place back on Feb 25 ’25, which means that Melcher David F is holding 76,681 shares at $177,646 based on the most recent closing price.
Stock Fundamentals for EMBC
Current profitability levels for the company are sitting at:
- 0.16 for the present operating margin
- 0.63 for the gross margin
The net margin for Embecta Corp stands at 0.05. The total capital return value is set at 0.2.
Based on Embecta Corp (EMBC), the company’s capital structure generated 1.9 points at debt to capital in total, while cash flow to debt ratio is standing at 0.03. The debt to equity ratio resting at -2.11. The interest coverage ratio of the stock is 2.99.
Currently, EBITDA for the company is 199.0 million with net debt to EBITDA at 6.65. When we switch over and look at the enterprise to sales, we see a ratio of 1.79. The receivables turnover for the company is 5.82for trailing twelve months and the total asset turnover is 0.96. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.48.
Conclusion
In a nutshell, Embecta Corp (EMBC) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
